Kenya joins global trial of Oxford University’s COVID-19 vaccine

“The vaccine candidate, known as ChAdOx1 nCoV-19, has been developed jointly with Astrazeneca and is being evaluated in four countries: Britain, South Africa, Brazil and now Kenya.”